v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net loss $ (12,358,543) $ (1,736,512)
Adjustments to reconcile net loss to net cash used for operating activities:    
Depreciation and amortization 621,435 421,096
Amortization of debt issuance costs 653,055 963,085
Loss on disposal of property, plant, and equipment 584
Change in fair value of convertible note option liability (60,000)
Change in fair value of warrant liabilities (3,205,566) (660,622)
Change in fair value of Earn-out Share Liability (2,197,400) (13,520,000)
Stock based compensation 1,090,483 759,123
Share based vendor payments as compensation for services 184,551 183,000
Share based payment as compensation for ELOC commitment fee 73,023 25,000
Unrealized foreign currency transaction (gain) loss (6,615) (218,537)
Noncash expense related to Share Issuance Agreements 630,463
Amortization of operating lease right of use assets 117,365
Changes in operating assets and liabilities:    
Receivables (171,086) (62,498)
Inventories 142,296 (705,230)
Prepaid and other current assets 14,054 119,002
Other assets (99,435) 53,493
Accounts payable (930,093) 2,576,523
Accrued expenses and deferred payables 397,322 (216,700)
Other current liabilities 63,620 569,269
Operating lease payments (121,579)
Net cash used in operating activities (15,097,852) (11,514,722)
Cash flows from investing activities    
Purchase of intangible assets and trademarks (176,859) (224,949)
Purchase of property and equipment (28,948)
Purchase of investments (253,984)
Net cash used in investing activities (459,791) (224,949)
Cash flows from financing activities    
Proceeds from revolving line of credit 1,300,000
Repayment of revolving line of credit (14,000,000)
Proceeds from related party notes 19,250,000 3,176,000
Proceeds from issuance of convertible notes 1,975,000 1,000,000
Proceeds from the issuance of shares under equity line of credit facility 100,000 836,766
Payment of offering costs (225,000)
Proceeds from the issuance of common stock, net of transaction costs 4,828,750
Proceeds from exercise of stock options 19
Proceeds from note payable 9,905,007
Net cash provided by financing activities 17,005,007 11,141,535
Effect of exchange rate changes on cash 4,365 (16,346)
Net increase (decrease) in cash 1,451,729 (614,482)
Cash and restricted cash at beginning of period 133,860 1,685,633
Cash and restricted cash at end of period 1,585,589 1,071,151
Non-cash activities    
Settlement of related party note payable and related party liabilities for preferred stock 23,010,921
Conversion of White Lion convertible notes into common stock 1,432,554  
Settlement of convertible notes for shares issued 833,379 700,000
Common stock issued under equity line of credit for warrant cancellation 350,000
Conversion of related party notes to common stock 3,176,000
Conversion of interest on related party notes to common stock 63,096
Crowdkeep asset acquisition 6,957,456
As reported within the consolidated balance sheets:    
Cash 530,589 1,071,151
Restricted cash 1,055,000
Total cash and restricted cash $ 1,585,589 $ 1,071,151